Abstract
Introduction Impaired attention performance is a significant burden to people with multiple sclerosis (MS). Brain connectivity fluctuates with transitions between cognitive states, so measurement of network dynamics during these conditions may help to understand MS-related attention impairment.
Methods In people with MS and healthy controls, attention was measured using the Attention Network Test. 3T MRI was used to measure structural connectivity and both static and dynamic functional connectivity in the attention-related fronto-parietal network (FPN) at rest and during an attentionally-demanding task. Groups were compared on connectivity of the FPN during rest and task performance. Relationships between network connectivity and attention performance were tested using linear regression.
Results The sample comprised 37 people with MS and 23 matched controls. At rest, people with MS had significantly lower structural connectivity (R2=0.13, p=0.004), lower static functional connectivity (R2=0.07, p=0.032) and higher dynamic functional connectivity (R2=0.08, p=0.026) of the FPN. Higher dynamic connectivity was significantly associated with poorer attention performance in people with MS (R2=0.20, p=0.008). During attention-task performance, static functional connectivity was greater in people with MS than controls (R2=0.10, p=0.008). The task-induced reduction in static connectivity (relative to rest) was directly related to attention performance (R2=0.23, p<0.001).
Conclusion Increased dynamic functional connectivity of the FPN at rest may be a useful indicator of deficits in sustained attention in people with MS. The transition from rest to active-attentive state is accompanied by an increase in dynamic connectivity, and decrease in static connectivity which may be helpful in understanding aetiology and treatment of attention impairment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funded by the UK MS Society (grant 988).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Nottingham Research Ethics Committee 2 (14/EM/0064).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Summary statistical data generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Original datasets analysed are not publicly available to protect patient information.
